Literature DB >> 7490112

Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.

M Hirokawa1, A Kitabayashi, J Kuroki, A B Miura.   

Abstract

We report here that B7/BB1 molecules expressed on activated T lymphocytes are involved in signal transduction. Anti-B7/BB1 monoclonal antibody (mAb) enhanced allogeneic proliferative responses against three different B lymphoma lines in a dose-dependent manner, while the same mAb inhibited T-cell response against allogeneic T cells expressing B7/BB1. Induction of B7/BB1 expression on T cells with allogeneic stimulation was confirmed by flow cytometric analysis. With the purified preactivated T cells as responder cells, anti-B7/BB1 mAb costimulated these primed T cells with coimmobilized anti-CD3 mAb. Moreover, cross-linking of B7/BB1 molecules induced protein tyrosine phosphorylation in preactivated T cells with a phosphorylation pattern distinct from those induced by signalling through other T-cell molecules. These results suggest that B7/BB1 molecules function not only as costimulatory ligands expressed on antigen-presenting cells but as receptors on T cells to transduce the costimulatory signals into the cells and may play a role for T-cell-T-cell interactions leading to clonal expansion of activated T lymphocytes. However, the physiological relevance of our finding remains to be explored.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490112      PMCID: PMC1383989     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation.

Authors:  T Mustelin; K M Coggeshall; N Isakov; A Altman
Journal:  Science       Date:  1990-03-30       Impact factor: 47.728

2.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.

Authors:  J D Fraser
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  B7, a B-cell-restricted antigen that identifies preactivated B cells.

Authors:  A S Freedman; G Freeman; J C Horowitz; J Daley; L M Nadler
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

6.  Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.

Authors:  S W Van Gool; J L Ceuppens; H Walter; M de Boer
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

7.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

Authors:  T Yokochi; R D Holly; E A Clark
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

Authors:  G A Van Seventer; Y Shimizu; K J Horgan; S Shaw
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  1 in total

1.  Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80.

Authors:  Samuel T Haile; Jacobus J Bosch; Nnenna I Agu; Annette M Zeender; Preethi Somasundaram; Minu K Srivastava; Sabine Britting; Julie B Wolf; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.